SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-24-001134
Filing Date
2024-02-22
Accepted
2024-02-22 19:00:12
Documents
1
Period of Report
2024-02-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3645
  Complete submission text file 0001683168-24-001134.txt   5224
Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581
Business Address
Bitterman Robert J (Reporting) CIK: 0001304395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 24666729

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)